Working… Menu

Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03079063
Recruitment Status : Completed
First Posted : March 14, 2017
Last Update Posted : February 4, 2021
Information provided by (Responsible Party):
AryoGen Pharmed Co.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 30, 2020
Actual Study Completion Date : January 28, 2021